A PHASE 3 PLACEBO-CONTROLLED, DOUBLE-BLIND RANDOMIZED WITHDRAWAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIIB074 IN SUBJECTS WITH TRIGEMINAL NEURALGIA

Registry ID

802NP301

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

BIOGEN MA INCORPORATED

Start date

2018-11-19

Last update

2017-02-17

Conditions

• NEUROPATHIC PAIN

Related clinical trials

• ECSTASY TO ALLEVIATE SEVERE CHRONIC NEUROPATHIC PAIN (EASE PAIN) TRIAL: A RANDOMIZED CONTROLLED PILOT TRIAL
• TREATMENT WITH PSILOCYBIN FOR CHRONIC NEUROPATHIC PAIN AND DEPRESSION (TRANSCEND): AN OPEN-LABEL CLINICAL TRIAL
• PSILOCYBIN FOR ENHANCED ANALGESIA IN CHRONIC NEUROPATHIC PAIN: A RANDOMIZED CONTROLLED PILOT TRIAL (PEACE-PAIN)
• CANNABINOIDS AND AN ANTI-INFLAMMATORY DIET FOR THE TREATMENT OF NEUROPATHIC PAIN AFTER SPINAL CORD INJURY: THE CATNP STUDY
• A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PARALLEL GROUP STUDY OF THE EFFICACY AND SAFETY OF PREGABALIN (BID) IN SUBJECTS WITH POST-TRAUMATIC PERIPHERAL NEUROPATHIC PAIN

View on source registry